Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arterial t-PA perfusion in DCD donor livers to prevent non-anastomotic biliary strictures after liver transplantation
NL-OMON39319Phase 3Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of tissue-plasminogen activator in biliary stricture (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: Incidence of non-anastomotic biliary strictures, NAS-related symptoms and hospitalizations and 1 more. Started Jun 2014; status: active, not recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
biliary stricture
Beyond the preview
Go deeper on NL-OMON39319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39319.